MedPath

Brief Intervention for Drug Abusing Adolescents

Phase 2
Completed
Conditions
Drug Abuse
Registration Number
NCT00350909
Lead Sponsor
University of Minnesota
Brief Summary

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.

Detailed Description

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.

Specifically, we propose a randomized clinical trial to evaluate the efficacy of a cognitive-behavioral therapy on key process and outcome dimensions among school-based youth with mild-to-moderate drug abuse (MMDA). The experimental treatment is designated Brief Cognitive Behavioral Intervention (BCBI) given its theoretical foundation in stage of change theory used to coordinate modules on Rational-Emotive Therapy and Problem Solving Therapy. BCBI will be compared against a second experimental treatment that consists of BCBI and a single parent session (BCBI+P) and an assessment only condition (control). The importance of clarifying mechanisms in drug treatment research will be explored with respect to a limited number of treatment and individual factors that have emerged as promising mediating and moderating factors, such as cognitive and problem solving factors, parenting practices, and peer group influences.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  1. student at a local school
  2. meets DSM-IV criteria for a substance abuse disorder for at least one drug
  3. student and parent both agree to participate in the intervention study
Exclusion Criteria
  1. meets criteria for at least one DSM-IV substance dependence disorder
  2. meets criteria for a psychotic disorder or a learning disability

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Drug use frequency and quantity at 1-, 3- and 12-months post-intervention.1 year post treatment
Secondary Outcome Measures
NameTimeMethod
HIV and sexual risk behaviors at the same time period.1 year post treatment

Trial Locations

Locations (1)

University of Minnesota

πŸ‡ΊπŸ‡Έ

Minneapolis, Minnesota, United States

University of Minnesota
πŸ‡ΊπŸ‡ΈMinneapolis, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.